Unknown

Dataset Information

LDHA Suppression Altering Metabolism Inhibits Tumor Progress by an Organic Arsenical.


ABSTRACT: Based on the potential therapeutic value in targeting metabolism for the treatment of cancer, an organic arsenical PDT-BIPA was fabricated, which exerted selective anti-cancer activity in vitro and in vivo via targeting lactate dehydrogenase A (LDHA) to remodel the metabolic pathway. In details, the precursor PDT-BIPA directly inhibited the function of LDHA and converted the glycolysis to oxidative phosphorylation causing ROS burst and mitochondrial dysfunction. PDT-BIPA also altered several gene expression, such as HIF-1α and C-myc, to support the metabolic remodeling. All these changes lead to caspase family-dependent cell apoptosis in vivo and in vitro without obvious side effect. Our results provided this organic arsenical precursor as a promising anticancer candidate and suggested met

SUBMITTER: Liu YJ 

PROVIDER: S-EPMC6940739 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature